Portman Square Capital LLP Viatris Inc Transaction History
Portman Square Capital LLP
- $2.36 Billion
- Q4 2024
A detailed history of Portman Square Capital LLP transactions in Viatris Inc stock. As of the latest transaction made, Portman Square Capital LLP holds 534,000 shares of VTRS stock, worth $6.03 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
534,000
Previous 182,800
192.12%
Holding current value
$6.03 Million
Previous $2.12 Million
213.29%
% of portfolio
0.28%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding VTRS
# of Institutions
1,095Shares Held
930MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA141MShares$1.59 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.05 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$713 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$708 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$551 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.7B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...